Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ruiz EY"'
Autor:
Cooper N; Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, Hammersmith Hospital, London, UK., Ghanima W; Department of Haemato-Oncology, Østfold Hospital Trust, Kalnes, Grålum, Norway.; Department of Haematology, Oslo University Hospital, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Vianelli N; Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Valcárcel D; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Barcelona, Spain., Yavaşoğlu İ; Department of Hematology, Adnan Menderes University, Aydın, Turkey., Melikyan A; National Research Center for Hematology, Moscow, Russia., Ruiz EY; Hematology-Oncology Unit, Department of Internal Medicine, School of Medicine, Universidad de La Frontera, Temuco, Chile., Haenig J; Novartis Pharma AG, Basel, Switzerland., Somenzi O; Novartis Pharma AG, Basel, Switzerland., Lee J; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Clark J; Novartis Pharma AG, Basel, Switzerland., Zhang Y; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Zaja F; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.; UCO Ematologia, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Jan; Vol. 99 (1), pp. 57-67. Date of Electronic Publication: 2023 Nov 28.
Autor:
Dimopoulos M; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece., Bringhen S; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy., Anttila P; Division of Hematology, Comprehensive Cancer Center, Helsinki University and Helsinki University Hospital, Helsinki, Finland., Capra M; Hospital Mãe de Deus, Porto Alegre, Brazil., Cavo M; 'Seràgnoli' Institute of Hematology, Sant'Orsola-Malpighi University Hospital, Bologna, Italy., Cole C; Division of Hematology and Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI., Gasparetto C; Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC., Hungria V; Department of Hematology, Clínica São Germano, São Paulo, Brazil., Jenner M; Department of Haematology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom., Vorobyev V; S.P. Botkin Hospital, Moscow, Russia., Ruiz EY; Clinical Oncology, Universidad de la Frontera, Temuco, Chile., Yin JY; Sanofi, Bridgewater, MA., Saleem R; Sanofi, Bridgewater, MA., Hellet M; Ividata (for Sanofi), Paris, France., Macé S; Sanofi, Paris, France., Paiva B; Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), CIBER-ONC number CB16/12/00369, Pamplona, Spain; and., Vij R; Division of Medical Oncology, Washington University, St. Louis, MO.
Publikováno v:
Blood [Blood] 2021 Mar 04; Vol. 137 (9), pp. 1154-1165.
Autor:
Bang YJ; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea. Electronic address: bangyj@snu.ac.kr., Ruiz EY; Universidad de la Frontera, Temuco, Chile., Van Cutsem E; Department of Digestive Oncology, University Hospitals Gasthuisberg/Leuven, KU Leuven, Leuven, Belgium., Lee KW; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea., Wyrwicz L; Department of Gastrointestinal Cancer, M. Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland., Schenker M; Centrul de Oncologie Sf. Nectarie, Craiova, Romania., Alsina M; Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain., Ryu MH; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea., Chung HC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea., Evesque L; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France., Al-Batran SE; Department of Clinical Oncology and Hematology, Krankenhaus Nordwest, Frankfurt, Germany., Park SH; Department of Medicine, Samsung Medical Center, Seoul, South Korea., Lichinitser M; Department of Chemotherapy and Combined Therapy, N. N. Blokhin Russian Oncological Scientific Center, Russian Academy of Medical Sciences, Moscow, Russian Federation., Boku N; Department of Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan., Moehler MH; Department of Internal Medicine, Johannes Gutenberg University Mainz, Mainz, Germany., Hong J; Global Clinical Development Immuno-Oncology, EMD Serono, Billerica, USA., Xiong H; Global Clinical Development Immuno-Oncology, EMD Serono, Billerica, USA., Hallwachs R; Global Research & Development, Merck KGaA, Darmstadt, Germany., Conti I; Global Clinical Development Immuno-Oncology, EMD Serono, Billerica, USA., Taieb J; Department of Gastroenterology and Digestive Oncology, Université Sorbonne Paris Cité, Paris Descartes University, Georges Pompidou European Hospital, Paris, France.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2018 Oct 01; Vol. 29 (10), pp. 2052-2060.